ACI

In the past six months, Albertsons' stock price has been impacted by several events. The proposed merger with Kroger was blocked by federal regulators in December 2024. Albertsons reported its fourth quarter and full year fiscal 2025 results on April 14, 2026, announcing a 0.7% increase in identical sales and a 16% increase in digital sales for the fourth quarter. Additionally, Albertsons declared a 13% increase in its common stock dividend and increased its share repurchase authorization to $2 billion. The company also completed a $750 million accelerated share purchase agreement on January 8, 2026. On April 14, 2026, Albertsons announced a national opioid settlement framework. The Inflation Reduction Act's Medicare Drug Price Negotiation Program, effective January 1, 2026, is expected to be a 150 basis point headwind for the company. As of May 4, 2026, the share price was $16.29, representing a decline of 24.93% over the past year.